Tag: Healthcare Policy

Washington's Medicare Adopts AI-Driven Prior Authorization Pilot in 2026

Starting in 2026, Washington state will implement an AI-driven prior authorization pilot for traditional Medicare, raising new compliance and access challenges. Learn about the pilot's impact on Medicare claims processing and healthcare providers.

Montana Faces Sharp ACA Premium Hikes as Enhanced Tax Credits Expire

Montana residents face health insurance premium increases up to 231% as enhanced ACA tax credits expire, impacting affordability and coverage decisions.

UnitedHealthcare to Remove Prior Authorizations for Select Imaging Procedures in 2026

UnitedHealthcare will stop requiring prior authorizations for certain nuclear imaging, obstetrical ultrasound, and echocardiogram procedures starting in 2026, across multiple plan types including Medicare Advantage and commercial plans.

Health Insurance Strategies for Women with Chronic Conditions During Open Enrollment

Explore effective health insurance strategies for women managing chronic illnesses during open enrollment, focusing on plan tiers, cost management, and provider networks.

U.S. Market Rally, Fed Chair Nomination, and Tennessee Election Shape December Outlook

Overview of U.S. stock market rally, Federal Reserve Chair nomination prospects, and Tennessee special election's impact on healthcare and insurance markets in December 2025.

Expiration of Enhanced Premium Tax Credits Threatens Health Coverage for Utah Small-Business Owners

Enhanced premium tax credits supporting health insurance affordability for Utah small-business owners face expiration, risking access to care for cancer patients and others.

Trump Administration Secures Medicare Drug Price Cuts for 15 Medications

The Trump administration finalizes agreements reducing Medicare prices for 15 drugs, aiming to save billions and impact Medicare Part D plans and drug affordability policies.

AdvaMed Highlights Access Concerns in CMS 2026 Home Health Payment Rule

AdvaMed responds to CMS 2026 payment rule, stressing patient access to diabetes and prosthetic supplies amid competitive bidding concerns.

Pharma Firms Slash Medicare Drug Prices in Trump Administration Deal

Pharmaceutical companies agree to significant Medicare drug price cuts under Trump administration, projecting billions in savings with impacts on Medicare Part D and drug affordability.

CMS Proposes Medicare Advantage Star Ratings Overhaul, Amid Legal and Operational Updates

CMS proposes to revamp Medicare Advantage Star Ratings, affecting insurer compliance and operations. Legal appeals and health system updates also impact the US market.